Kepler Capital analyst Fabienne Caron maintained a Sell rating on Ocado Group (OCDGF – Research Report) on July 21 and set a price target of p859.00. The company’s shares closed last Thursday at $9.00, close to its 52-week low of $8.50.
Caron has an average return of 36.3% when recommending Ocado Group.
According to TipRanks.com, Caron is ranked #4946 out of 7952 analysts.
Currently, the analyst consensus on Ocado Group is a Hold with an average price target of $12.89.
The company has a one-year high of $28.85 and a one-year low of $8.50. Currently, Ocado Group has an average volume of 2,932.
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of OCDGF in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Ocado Group Plc engages in the operation of online grocery supermarket. It operates through the following segments: Retail, UK Solutions & Logistics, and International Solutions. The Retail segment provides online grocery and general merchandise offerings to customers within the UK. The UK Solutions & Logistics segment reflects contracts with the Ocado Retail joint venture and Morrisons, inclusive of both solutions contracts and service agreements with Ocado Logistics for the provision of third party logistics and other services. The International Solutions segment deals with international partners for the provision of Ocado Smart Platform. The company was founded by Jonathan Faiman, Jason Gissing, and Timothy Steiner in April 2000 and is headquartered in Hatfield, the United Kingdom.
Read More on OCDGF:
- O3 Mining Announces Share Disposition
- Osisko Development Announces Filing of the Technical Report for the San Antonio Mineral Resource Estimate, Sonora State, Mexico
- Wall Street is Bullish on These 3 Oversold Payment Stocks
- HII’s Ingalls Shipbuilding Awarded DDG(X) Design Engineering Contract
- Revelation Biosciences Inc. Announces Topline Data for Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis